반응형
There are currently 53 devices enrolled in the FDA’s TAP Pilot.
On October 1, 2024, the Total Product Life Cycle Advisory Program (TAP) Pilot expanded to include medical devices reviewed by the Division of Ophthalmic Devices (DHT1A) and the Office of Radiological Health (OHT8).
The TAP Pilot is now accepting enrollment requests for Breakthrough Designated devices reviewed by the:
- Division of Ophthalmic Devices (DHT1A)
- Office of Cardiovascular Devices (OHT2)
- Office of Neurological and Physical Medicine Devices (OHT5)
- Office of Radiological Health (OHT8)
Total Product Life Cycle Advisory Program (TAP) | FDA
반응형